Contrarily, hyperactive Nrf2 is also reconsidered a potent oncogenic driver with the hallmarks of cancer because of its bona fide tumor-promoting effects on carcinogenesis, cancer progression, metastasis, and resistance to therapy [22, 23]. This evidence concerns the gene NFE2L2 and neoplasm.